hạt nano kim loại và thuốc chữa bệnh

1179 ISSN 2041-599010.4155/TDE.13.74 © 2013 Future Science Ltd Ther. Deliv. (2 013 ) 4 (9 ), 1179–119 6 Review Nanostructured metallic films approximately 200–500 nm thick have been a part of ceramic decorations ‘luster’ since the medieval period. The homogeneous dispersion of silver and cop- per nanoparticles over glazed pottery results in a colored iridescence called luster, a technique very popular in the Middle East, Egypt, Persia and Spain. In 1685, Andreas Cassius invented a recipe of glass coloring pigment called Purple of Cassius. He made the purple precipitates by dissolving gold particles in aqua regia and then added a piece of tin to it. The pigment is famous for its use in high-quality porcelain ware. A Vien- nese chemist, Richard Zsigmondy was awarded the Nobel Prize in Chemistry in 1925 for discov- ering that colloidal gold adsorbed on stannous hydroxide base makes Purple of Cassius. Michael Faraday (1857) prepared gold sols, whose size was found out by JM Thomas in 1988 to be 3–30 nm in diameter, when he reproduced those gold nanoparticles. Industrial nanotechnology was initiated in 1930 with the manufacturing of sil- ver coatings for photographic films. At around this time imaging techniques such as ultrasound, MRI, computed tomography, positron emission tomography and surface enhanced raman spec- troscopy were becoming popular for imaging various disease states and magnetic nanopar- ticles came to the rescue as contrast agent with unique physicochemical properties. The 1980s took nanomaterials to higher strata by introduc- ing fullerenes and scanning tunnel microscopes. In the mid-1980s, when growth technologies such as molecular beam epitaxy tied nuptials with electron-beam lithography to confine electron motion in all three (x-y-z) directions, quantum dots (Q-dots) were produced. These metallic nanoparticles have been embraced by nanotechnology for more than four decades now. Today, with Q-dots as new nanoball bearings, aluminosilicates as nanowire gauges, cochle- ates as nanocrystalline delivery trucks and iron nanoparticles as new biomagnets, it is no wonder that nanoscience thinks about metals in terms of size control, spatial resolution, chemical reac- tivity and engineering their relationship at the cellular level in real time. Metal nanoparticles can be easily prepared to the nanometer scale, they possess fundamentals of light matter interaction and are highly suitable Metallic nanoparticles and their medicinal potential. Part II: aluminosilicates, nanobiomagnets, quantum dots and cochleates Metallic miniaturization techniques have taken metals to nanoscale size where they can display fascinating properties and their potential applications in medicine. In recent years, metal nanoparticles such as aluminium, silicon, iron, cadmium, selenium, indium and calcium, which find their presence in aluminosilicates, nanobiomagnets, quantum dots (Q-dots) and cochleates, have caught attention of medical industries. The increasing impact of metallic nanoparticles in life sciences has significantly advanced the production techniques for these nanoparticles. In this Review, the various methods for the synthesis of nanoparticles are outlined, followed by their physicochemical properties, some recent applications in wound healing, diagnostic imaging, biosensing, assay labeling, antimicrobial activity, cancer therapy and drug delivery are listed, and finally their toxicological impacts are revised. The first half of this article describes the medicinal uses of two noble nanoparticles – gold and silver. This Review provides further information on the ability of aluminum, silicon, iron, selenium, indium, calcium and zinc to be used as nanoparticles in biomedical sciences. Aluminosilicates find their utility in wound healing and antibacterial growth. Iron-oxide nanoparticles enhance the properties of MRI contrast agents and are also used as biomagnets. Cadmium, selenium, tellurium and indium form the core nanostructures of tiny Q-dots used in cellular assay labeling, high-resolution cell imaging and biosensing. Cochleates have the bivalent nano ions calcium, magnesium or zinc imbedded in their structures and are considered to be highly effective agents for drug and gene delivery. The aluminosilicates, nanobiomagnets, Q-dots and cochleates are discussed in the light of their properties, synthesis and utility. Leena Loomba 1 & Tiziano Scarabelli* 2,3 1 Punjab Agricultural University, Ludhiana, Punjab, India 2 Center for Heart & Vessel Preclinical Studies, St. John Hospital & Medical Center, Wayne State University School of Medicine, Detroit, MI, USA 3 Medical Center, Wayne State University School of Medicine, MI, USA *Author for correspondence: E-mail: tiziano.scarabelli@wayne.edu For reprint orders, please contact reprints@future-science.com Review | Loomba & Scarabelli The r. Del iv. (2013) 4(9) 1180 future science group for conjugation with drugs, ligands, antibod- ies and genes, as well as functional groups of interest. Excitation and relaxation of conduction band electrons in metallic nanoparticles results in plasmon resonance – a unique phenomenon responsible for energy dissipation and optical effects. An effective cellular communication, the invincible ability of nanometals provides immense possibility for their growth and devel- opment in biomedicine. Nanoparticles have been synthesized, tested, used and modified over the years to function as agents for gene therapy, DNA sequencing, cancer detection, cellular tracking, targeted drug delivery and biomedical imaging. The versatile attitude of metallic nanoparticles attracts scientific research and clinical appli- cations under the stream of nanotechnology (Table 1). Aluminosilicate nanoparticles  Types, properties & synthesis of aluminosilicate nanoparticles Types Aluminosilicates are broadly classified into the following categories (FiguRe 1):  Orthosilicates with [AlO 6 ] 3- anions connected by isolated (SiO 4 ) 4- clusters; for example, andalusite (Al 2 SiO 5 ) and its polymorphs, kyanite and sillimanite;  Phyllosilicates with tetrahedral and octahedral layers in two dimensions; for example, kaolinite, smectite and illite;  Cyclosilicates with tetrahedral clusters of (Si 3 O 7 ) 6- , (Si 4 O 12 ) 8- or (Si 6 O 18 ) 12- arranged in a cyclic manner; for example, bentonite (BaTi[Si 3 O 9 ]) and beryl (Be 3 Al 2 [Si 6 O 18 ]). Properties Aluminosilicates are minerals consisting of alu- minium and silicon oxides. Silicates are tetra- hedrally clustered polymers of (SiO 4 ) 4- anions. The positively charged ions of Al 3+ can either substitute silica atoms in the silicate tetrahedra or connect outside the anionic framework, to form aluminosilicates. In nature, magma solid- ifies to form aluminosilicates such as feldspar (xAl[Al,Si] 3 O 8 , where x can be Na, K or Ca), mica, beryl or wollastonite. In feldspar the Al 3+ ion replaces the Si 4+ cation of (SiO4) 4- , leaving behind a negative charge on the 3D framework. The positively charged ions neutralize this negative charge, for example, K + in microcline (KAlSi 3 O 8 ) and Na + in albite (NaAlSi 3 O 8) , both K + and Na + in sanidine ([K,Na]AlSi 3 O 8 ] 4 ) and Ca 2+ in Anorthite (Ca[AlSi 2 O 8 ]). The weather plays its role to convert feldspar to clay kaolin (Al 2 Si 2 O 5 [OH] 4 ) or montmorillonite ([Na,Ca] 0.33 [Al,Mg] 2 [Si 4 O 10 ][OH] 2 .nH 2 O). Naturally occurring aluminosilicate nanopar- ticles exist as nanotubes called imogolites, or hollow 3–5 nm spherical allophanes. Both these aluminosilicates have on identical chemical com- position (Al 2 SiO 3 [OH]) 4 , but with different structures depending on the Al/Si ratio. Clay has negatively charged sites that can attract and hold positively charged particles and this is called ‘cation exchange capacity’; it is the measure of how many negatively charged sites are available on a nanoparticles surface. These exchange reactions are rapid, reversible and stoichiometric with respect to charge: 2{K + -Soil} + Ca 2+ → 2K + + Ca 2+ –(Soil) 2 equaTion 1 Aluminosilicate nanoparticles undergo ion exchange readily, that is, adsorbed cations can be replaced by a large quantity of other com- peting ions, which superimpose their strength and resistance. The layered sheet-like structure of aluminosilicate nanoparticles provides addi- tional surface area as well as the ability to hold substances for targeted delivery. Kaolinites are 1:1 aluminium phyllosilicates having the chemical formula Al 2 Si 2 O 5 (OH) 4 . Clays such as kaolinite, dichite, nacrite and hal- loysite fall under this category. They have SiO 4 tetrahedrons and AlO 4 octahedrons arranged in Table 1. Examples of metallic nanoparticles used as drugs and diagnostic agents. Metallic nanoparticles Element Use Aluminosilicate nanoparticles Al, Si Faster blood clotting in open wounds Nano biomagnets Fe Helps in targeted drug delivery Q-dots Cd, Se, In Medical imaging Cochleates Ca, Zn, Mg Oral drug delivery of drugs encapsulated in a nanocrystalline structure Metallic nanoparticles & their medicinal potential | Review www.future-science.com 1181 future science group a 2D hexagonal array. This arrangement twists the tetrahedral sheet, flattens the octahedral sheet and compels the hexagonal arrangement to distort in a ditrigonal manner. Smectites and illites are 2:1 bonded sheets of aluminium phyllosilicates with an octahedral sheet sandwiched between two tetrahedral sheets (TOT). The space between two TOT sheets is occupied by cations and/or water molecules. The arrangement can be designated as TOT (H 2 O/ cations) TOT. Smectites have the chemical for- mula: Na 0.3 Al 2 (Si 3.7 Al 0.3 )O 10 (OH) 2 and examples include montmonrillonite, nantronite, saponite and hectorite. They have high cation exchange capacity, a very large chemically active surface area and an unusual tendency to hold water molecules in the interlamellar surface. Illites have the chemi- cal formula K 0.7 Al 2 (Si 3.3 Al 0.7 )O 10 (OH) 2 . The cat- ion exchange capacity of the illite group is midway between that of kaolinite and smectite, but their hydration capacity is low due to the replacement of Na + ions by K + ions. Synthesis Mesoporous aluminosilicate nanoparticles with narrow size distribution (30–50 nm) are syn- thesized by a hydrothermal method using cet- yltrimethylammonium bromide as a template and polyethylene glycol as a means to tailor the nanoparticles [1]. The aluminium salt, alumi- num nitrate nonahydrate, catalyzes the hydroly- sis of the silica precursor tetraethyl orthosilicate. The hydrolyzed species can be rapidly assembled into mesostructured nanocomposites under the direction of cationic micelles with the addition of basic ammonia water. The nonionic polyeth- ylene glycol shields the formed nanoparticles through hydrogen-bonding interactions, thereby tuning the grain size distribution of mesoporous nanoparticles. A sol–gel route has been used to synthesize aluminosilicates, with varying alu- mina–silica ratios. The process uses boehmite and tetraethyl orthosilicate as alumina and silica precursors, respectively [2].  Aluminosilicate nanoparticles in medicine Clay has been popular since the prehistoric era in bath spas to preserve complexion; in ochres to cure wounds caused by serpents, to reduce the flow from the lachrymal ducts; against hemor- rhage, inflammation, gastrointestinal infections and kidney diseases; and even to make mum- mies. Modern physicians use the same clay parti- cles at a nanoscale level in bandages, antibacterial ointments and pharmaceutical carriers. Kaolinites are known for wound healing Kaolin clay has long been used for curing inju- ries, festering inflammations and healing wounds. From the 1950s kaolin has been an activating agent for a clotting test that doctors perform routinely. The clay is predominantly rich in alu- minosilicate nanoparticles that have the ability to reduce staunch bleeding by absorbing water; resulting in quick blood clotting [101]. The surgical dressings, impregnated with kaolin, are sold under the tradename ‘QuickClot ® ’ and are used to com- bat life-threatening hemorrhage on the battlefield. The presence of kaolin on the surface of nonwo- ven rayon gauge leads to enhanced transformation of factor XII, factor XI and prekallikrein to their activated forms; this activation further initiates the coagulation cascade of hemostasis. Chemists at the University of California (Santa Barbara, CA, USA), realized that the aluminosilicate nanoparticles could be used to halt severe nose bleeds. The inorganic specks, which are derived from kaolin clay, when infused with a bandage, Aluminiosilicates Orthosilicates Phyllosilicates Cyclosilicates Examples: andalusite, kyanite, sillimanite (used in ceramics, boiler furnaces and kiln linings). Examples: kaolinite, smectite, illite (used in wound healing, burns, sepsis and inflammation) Examples: bentonite, beryl (used as a laxative and anti-inflammatory agents) Figure 1. Various types of aluminosilicates and their uses. Review | Loomba & Scarabelli The r. Del iv. (2013) 4(9) 1182 future science group trigger the body’s natural clotting process. The bandage stops the bleeding immediately, when rolled up and inserted in the nose [102]. Smectites & illites possess antibacterial ability Smectites are famous for their tendency to absorb the carcinogenic metabolite aflatoxin B1, produced by the fungi Aspergillus flavus in animal diet [3]. The nanoparticles of smectites– illites and reduced iron present in natural clay have the potential to eliminate Escherichia coli and even antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus. The hydrated clay leaches into the bacterial cell mem- brane to increase bacterial iron and phosphorous levels and metabolic activity of the membrane. The regulatory proteins subsequently come into action to oxidize Fe 2+ to Fe 3+ and even produce hydroxyl radicals, which enter the cytoplasm and cause cell death [4]. The in vitro antibacterial activity of clay min- erals has proven effective against Buruli ulcer and b-lactamase E. coli. The mineral surfaces of aluminosilicates in clay alter pH and oxidation states in bacterial membranes to control redox reactions, resulting in cell lysis [5]. The layered metal hydroxides of clay behave as excellent pharmaceutical carriers. The lamellar surfaces of various layers can easily hybridize nano- medicines in their 2D structure. For example, methotrextate – a folate antagonist anticancer drug – is unstable and also has a short plasma half-life. The drug, when layered in Mg and Al hydroxides of clay, specifically suppresses growth of human osteosarcoma cancer cells [6]. Bentonite: a versatile aluminisilicate Bentonite is a chemically inert, absorbent alu- minium phyllosilicate consisting of montmoril- lonite. Bentonite supports good digestion and acts as a laxative. In the gastrointestinal tract of animals bentonite reduces bacterial mucolysis and inflammation. The granular form of benton- ite is used under the commercial name ‘Wound- Stat™’, in battlefields for wound dressings. It reduces pain associated with stings, burns and cuts, promotes detoxification and also shields against urushiol – the oil found in poison ivy. Nanobiomagnets  Types, properties & synthesis of nanobiomagnets Types The nanosized, biocompatible, paramag- netic iron oxides that serve as biomagnets are magnetite (Fe 3 O 4 ), maghemite (g-Fe 2 O 3 ) and haematite (a-Fe 2 O 3 ); of which magnetite, because of its biocompatibility, is very promis- ing. Iron oxide nanoparticles (IONps) are avail- able in various dimensions and shapes such as nanorods, nanotubes, hollow fibers, rings and snowflakes. The iron oxide nanorods demonstrate higher incident photon-to-current conversion compared with nanospheres, which is further improved by surface modification and doping with Zn. The nanoparticle size imposes a huge impact on superparamagnetism and, in turn, their usage. Generally, iron oxide nanoparticles ranging from 1 to 25 nm are highly efficient models. Super- paramagnetic iron oxide nanoparticles are of particular interest in MRI; examples include:  AMI-227 (Sinerem, Combidex ® ) and SHU- 55C – a 20 nm sized iron oxide nanoparticle coated with carbodextran. It demonstrates excellent T2 relaxivities of 151.0 mmol/sec and has been used for lymph node and bone marrow imaging.  OMP (Abdoscan ® ) and AMI-121 (Lumirem ® , GastroMARK ® ) are 300 nm sized iron oxide nanoparticles (IONps) coated with silica. Their oral administration finds utility as a gastrointestinal contrast. Properties In magnetite, Fe 3+ ions are placed at all tetrahe- dral sites, whereas both ferrous and ferric ions occupy octahedral sites of inverse spinel struc- ture. Maghemite is the oxidized form of mag- netite having 56 ions in each unit cell, of which 32 are O 2- ions, eight Fe 3+ ions in tetrahedral sites and 16 Fe 3+ in octahedral sites. Magne- tite is a spin-polarized black crystal containing both Fe (II), Fe (III) and absorbs throughout the UV–vis–IR spectrum, while maghemite is an insulator. Both phases are ferrimagnetic. Haematite, a-Fe 2 O 3 , has a 3D framework built up of trigonally distorted octahedra FeO 6 , with oxygens in hexagonal closest-packing. The tri- valent iron ions are closely packed between two oxygen layers. This arrangement makes the structure neutral with no excess charge. Haematite has antiferromagnetic properties and an absorption spectrum in the visible range between 295 and 600 nm. The magnetic behav- ior of these oxides is due to their stereochem- istry that triggers internal superexchange com- petition between tetrahedral and octahedral Metallic nanoparticles & their medicinal potential | Review www.future-science.com 1183 future science group sites. At room temperature both magnetite and maghemite are superpara magnetic, which means an external magnetic field can easily magnetize the nanoparticles. The IONps need to be superparamagnetic, biocompatible and nontoxic to be useful for molecular imaging purposes. They also need to bind to a range of metabolites. The zero point charge value of seven makes oxides stable only in highly acidic or basic aqueous media. This drawback in their surface chemistry causes con- siderable aggregation and precipitation in solu- tion phase. Also, low hole mobility, electron- hole recombination and electon-trapping, and oxygen-deficient iron sites yield poor photocur- rent efficiency. However, coating the particles with silica, dextran, carbodextran, poloxamines or poly(ethylene glycol) followed by their bio- conjugation with various ligands gives them both stability and specificity. Magnetic iron- oxides need high r1 and r2 relaxivities, as well as surface engineering, to fine tune their size and structure, before being used for in vivo applications [7]. The ferromagnetic nanoparticles magnetiza- tion fluctuates with temperature, fluctuations are generally larger at higher temperatures and smaller at lower temperatures. When the time between two magnetization fluctuations (Néel relaxation time) is shorter than the time used to measure the magnetization of the nanoparticles, in the absence of external magnetic field, the nanoparticles show an average zero magnetiza- tion. This is called superparamagnetism. Mate- rials having superparamagnetism have a high saturation magnetization and zero coercivity and remanence. The Néel relaxation time is highly tempera- ture dependent, it fluctuates randomly by ther- mal fluctuation at high enough temperatures. The thermal energy decreases at lower tempera- tures and blocks the magnetic moments. This temperature is called the blocking temperature. It is a function of the particle size and increases with increasing particle size. Thus, superpara- magnetism increases with the decrease in size of the nanoparticle. Below blocking tempera- ture, the preferred direction of magnetization of superparamagnetic material is lost in zero magnetic fields. When the temperature rises above the blocking temperature, the nanopar- ticles show no hysteresis. With these fascinating superparamagnetic properties, IONps find their utility in ferrofluids, hyperthermia and MRI contrast agents. Synthesis Reverse micelle and precipitation are two com- monly used techniques for the synthesis of iron oxides [8]. The simplest of all the methods to prepare IONps is the coprecipitation of a 2:1 stoichiometric mixture of Fe 2+ /Fe 3+ salts in an aqueous medium of pH between 8 and 14. The magnetite forms black colored precipitates. The overall reaction is written as: Fe 2+ + 2Fe 3+ + 8OH - → Fe 3 O 4 + 4H 2 O equaTion 2 The particle size depends on numerous fac- tors such as Fe 3+ /Fe 2+ ratio, temperature, ionic strength, nature of salts, pH and addition of che- lating agents. Generally, the nanoparticle size decreases with an increase in the pH, Fe 3+ /Fe 2+ ratio and ionic strength of the medium. The aqueous iron salt solutions essentially form reverse micelles with the hydrophilic head towards the core of the micelle and the hydro- phobic tail directed outwards. Reverse micelles solubilize large amounts of water, which can be controlled, for nanoparticle production. A wide range of iron oxide nanoparticles can be syn- thesized by altering the nature and amount of surfactant, solvent and cosurfactant. They can also be synthesized using techniques such as sonochemistry, microwave irradiation and autogenic pressure reactor [9]. A new method to produce nanocrystals is glass crystallization [10]. In total, 15–20 nm sized, monodisperse, Fe 3 O 4 nanoparticles are synthesized by decom- position of iron (II) acetate at 400°C. IONps of desired size and dispersity are also synthesized by heating iron-oleic complex at 320°C in 1-octa- decene for 30 min. Hydrothermal treatment of iron powder and iron chloride solution in urea solution for 20 h at 130–150°C yields iron rods of nearly 80 nm.  Photoelectrochemical applications of biomagnets The chemistry of iron oxide nanoparticles can be manipulated to have magnetic properties that find their importance in magnetic reso- nance imaging, biotechnology and effective hyperthermia (FiguRe 2). Iron-oxide nanoparticles as hyperthermia & MRI contrast agents MRI is a noninvasive technique that combines the characteristics of high spatial resolution, Review | Loomba & Scarabelli The r. Del iv. (2013) 4(9) 1184 future science group nonionizing radiation and multiplanar tomog- raphies in cellular imaging. Superparamagnetic iron oxide nanoparticles comprise a class of novel MRI contrast agents that are composed of a ferrous iron (Fe 2+ ) and ferric iron (Fe 3+ ) core, and a layer of dextran or other polysaccharide coating [11]. The iron nanoparticles have a very large magnetic moment, which leads to local magnetic field inhomogeneity. Consequently, they serve to enhance the image contrast and, thus, improve the sensitivity and specificity of MRI in mapping information from tissues [12]. In vivo, nonspecific superparamagnetic iron oxide nanoparticles are mainly captured by the reticuloendothelial system, and they are more suitable for liver, spleen and lymph node imaging [13]. Because of their long plasma half-life, super- paramagnetic iron oxides are also used as blood pool agents in magnetic resonance angiography. Haematite nanoparticles, 1.8 nm in size, when coated with polysaccharides such as chi- tosan and alginate, respond superparamagneti- cally with very low coercivity. These nanopar- ticles can either be converted to magnetite by reduction or used directly for imaging [14]. The intensity of magnetic field of iron-based nanoparticles, having a layer of bis-carboxyl-ter- minated poly(ethylene glycol) on them, induces more effective hyperthermia than uncoated iron particles. They are far better MRI contrast agents and provide a focused approach for in vivo applications and cancer therapy [15]. Iron oxide nanoparticles manipulated with Herceptin ® – an antibody present in breast cancer cells – or chlorotoxin – a peptide that binds MMP-2 in gliomas, show enhanced in vivo tumor-targeting properties [16]. Mammary tumors contain over- expressed levels of urokinase-type plasminogen activator. Amino-terminal fragment conjugated IONps can effectively bind the over expressed receptors in breast cancer tissues and help in vivo imaging [17]. The nanocomposites of maghemite, such as those with bentonite and raffinose-mod- ified trypsin, are used as MRI contrast agents for the gastrointestinal tract and magnetic carriers for trypsin immobilization, respectively [18]. Flu- orescence and magnetism can be uniquely com- bined over maghemite nanoparticles. Congo-red or rhodamine dyes hybridize with g-Fe 2 O 3 to serve as biomarkers for in vivo Alzheimer’s dis- ease diagnosis [19]. Ferrite nanoparticles ranging from 20 to 200 nm in diameter are being used for biosensing and as contrast agents for MRI, when attached with europium these spheres can emit fluorescent radiations at 618 nm to help detect cancer [20]. Nanobiomagnets in biotechnology Biotechnology can rely on the magnetic powers of IONps to separate specific proteins from a group of biomolecules. For example, dopamine grafted IONps can be used for protein separa- tion. The bidentate enediol ligands of the dopa- mine molecule tightly bind with unsaturated iron sites. The nanostructures so produced enhance specificity for protein separation and provide tremendous stability to heating and high salt concentrations. In the same manner, mag- netic nanoparticles are ideal candidates for gene detection. In the diagnosis of diseases involving genetic expression, the separation of rare DNA/ mRNA targets with single-base mismatches in a mixture of various bio complexes is criti- cally important. Genomagnetic nano capturers have been formulated using IONps to detect DNA/RNA molecules with one single-base dif- ference. Nanobiomagnets can transfer drugs into the body and are held at the target site by an external magnet. The purpose of this is to concentrate the drug at the tumor site for long enough for it to be absorbed and release the drug on demand. The control of drug delivery using biomagnets can reduce the dosage by 60–75%, thus enhancing drug efficacy while decreasing Nanobiomagnets Magnetite Maghemite Haematite Used in hyperthermia, in biotechnology as genomagnetic capturer, as MRI contrast agents and to magnetically focus the drug at tumor sites Photoelectrochemical applications Figure 2. Nanobiomagnets and their photochemical applications. Metallic nanoparticles & their medicinal potential | Review www.future-science.com 1185 future science group unwanted systemic uptake. This mechanism can find its utility in control of insulin-dependent diabetes. Recent studies report that the iron oxide nanoparticles can adhere to red blood cell’s surface for nearly 4 months. This can help to release drugs slowly into the body and can lead to controlled treatment of many immunogenic diseases. Q-dots  Types, properties & synthesis of Q-dots Types Q-dots are tiny particles, traditionally chal- cogenides (selenides or sulfides) of metal such as cadmium or zinc (CdSe/ZnS) ranging from 2 to 10 nm. The electrons and holes of the semiconductor cores being confined to a point significantly modifies the energy spec- trum of the carriers. Q-dots have a metallic core made of semiconductors, noble metals, and magnetic transition metals, shielded by a shell. Depending on the variation in the con- stituents of the core, Q-dots are classified into various groups:  Group II–IV series Q-dots contains ZnS, ZnSe, CdSe and CdTe cores;  Group III–V series Q-dots have InAs, InP, GaAs and GaN cores;  Group IV-VI series Q-dots have PbTe, SnTe, SnS and SnS 2 cores. Q-dots are also classified as Type-I, Reverse Type-I and Type-II:  Type-I Q-dots have a core that simultaneously traps electrons and holes giving rise to contravariant band layout so that both the conduction and valence band edges of the core lie within the bandgap of the shell; for example, CdSe/CdS, CdSe/ZnS and InAs/CdSe;  For reverse Type-I Q-dots, the bandgap of the core is wider than the shell, and the conduc- tion and valence band edges of the shell lie in the core; for example, CdS/HgS, CdS/CdSe and ZnSe/CdSe;  Type-II Q-dots have one type of charge carrier in the core while the shell carries the other type. It maintains covariant band layout in which the valence and conduction band edge are either lower or higher than the band edges of the shell; for example, Type-II Q-dots that attract holes are GaSb/GaAs and Ge/Si, and those that attract electrons are InP/InGaP and InP/GaAs. Properties Q-dots are basically made of three parts – a core, a shell and the outer coating (FiguRe 3). The core region, when excited by a photon, triggers its electron in the semiconductor band gap, leaving behind a positive hole in the lower energy band. An increase in excitation increases the absorption in the band gap giving rise to broad absorption spectrum. Since the energy gap between higher and lower energy bands is responsible for emission energy, and the energy gap is low, the emission spectrum is narrow. The shell covers the surface defects of the elec- tron–hole nanocore, and thus protects it from oxidation, fluorescence and chemical reactions. The shells having large energy gaps increase the quantum yield and enhance photostability. A Q-dot core (CdSe) Shell (ZnS) Cap (disulfide bridge, silane) S Biomolecule (protein/DNA) Biological applications Cellular and assay labeling High-resolution cell imaging Q-dot-FRET biosensing Figure 3. A biofunctional quantum dot and its biological applications. FRET: Fluorescence resonance energy transfer; Q-dot: Quantum dot; S: Sulfide bridge. Review | Loomba & Scarabelli The r. Del iv. (2013) 4(9) 1186 future science group coating of functional ligands over the Q-dot shell improves their solubility in polar solvents and also labels them. The mono or dithiol dihy- drolipoic acid ligands improve stability for over 1–2 years; phospholipids induces stability over a wide pH range while thiolated peptides or poly histidine residues provide both dispersion and bio-functionalization. The electronic properties of Q-dots are inter- mediate between those of bulk semiconductors and discrete molecules. The most apparent of these is the emission of photons under excitation, which are visible to the human eye as light. The wavelength of these photon emissions depends on their size. The smaller the dot, the closer it is to the blue end of the spectrum and the larger the dot, the closer to the red end. The charac- teristics of Q-dots that attract the attention of biomedicine are brightness, time resolved imag- ing because of 20 s lifetime of fluorescence, and the ability to image many colors simultaneously without overlapping, due to narrow fluorescence emission. Moreover, Q-dots require a mini- mum amount of energy to induce fluorescence, resulting in high quantum yields. Their core- shell structure makes them highly stable against photobleaching. Synthesis The binary semiconductor nanocrystals such as cadmium selenide, cadmium sulfide, indium arsenide and indium phosphide could be synthesized by fabrication, colloidal syn- thesis or as viral assembly. Bulk quantities of semiconductor dots are produced by colloidal synthesis based on a three-component system composed of precursors, organic surfactants and solvents. The high temperature turns the reaction medium to monomers [21]. Fabrica- tion produces 5–50 nm sized dots, defined by lithographically patterned gate electrodes, or by etching on 2D electron gases in semiconductor heterostructures [22 ]. The biocomposite struc- tures of Q-dots could be genetically engineered using bacteriophage viruses (TMV, M13 or Fd) [23]. Subjecting the organometallic precursors (CdO, Cd-acetate) and solvent-ligand (trioctyl phosphine–tri octyl phosphine oxide) mixture to high temperatures yields CdSe Q-dots with high crystalline cores.  The utility of Q-dots in medicine The initial Q-dot bioconjugate was reported in 1998. Over the past decade, the study of Q-dots has extended from high-resolution cellular imaging to labeling, tumor targeting, and diagnostics. Q-dots in cellular & assay labeling When introduced in cells, Q-dots found applica- tions in cell tracking, immunoassays, determin- ing the metastatic potential of cells and unleash- ing various cellular and metabolic processes. The labeling of cells and assays with Q-dots is an initial step of imaging processes and can be achieved by extracellular or intracellular modes. The proteins as well as receptors associated with membranes help in extracellular labeling of Q-dots to understand biological pathways such as signal transduction, chemotaxis, cel- lular organization and diffusion behavior of metabolites. Studies have been successfully carried out with biotinylated-coated dots and glycosyl–phosphatidyl–inositol conjugated avi- din Q-dots to understand the diffusive behavior of the plasma membrane [24]. To demonstrate intracellular labeling, cells can be microinjected or incubated with Q-dots via nonspecific endocytosis. The peptide-medi- ated intracellular delivery of Q-dots allows pas- sive intake of biomolecules, such as cytokeratin, mortalin, microtubules, liposomes and oligonu- cleotides, into the cells. The streptavidin–biotin complex links easily, through covalent bonding to the Q-dot surface to control intracellular delivery. The difference between invasive and non- invasive cancer cell lines can be demonstrated by in vitro cell motility assay based on the phago- kinetic uptake of Q-dots. The cell lines move across the homogeneous layer of Q-dots and leave a fluorescent-free trail. On calculating the ratio of trail-to-cell area, the tumor invasiveness can be easily distinguished. Q-dots coated with DNA serve as probes for the detection of multiallele DNA and human metaphase chromosomes. They also act as spe- cific DNA labels for highly sensitive in situ hybridizations [25]. Multiple toxin ana lysis in immunoassays and marking Her2 breast cancer cells has been possible by conjugating Q-dots with antibodies [26]. Q-dots have also been used to diffuse glycine receptors in neurons and in near-infrared emission identification of lymph nodes during live animal surgery [27]. Recently, CdTe Q-dots have been reported to control the nerve cells. Light energy excites electrons in the Q-dot, which causes the immediate environment to become negatively charged. This cause the ion channels to open Metallic nanoparticles & their medicinal potential | Review www.future-science.com 1187 future science group in the cancerous tissue, allowing the thorough- fare of ions in and out of the cells. The ion channel openings generate action potential over nerve cells, which in turn can be controlled by external voltage on Q-dots to depolarize the unwanted cells [28]. High-resolution cell imaging with the help of Q-dots Q-dots have the ability to overcome the limi- tations of fluorescence imaging of live tissues, which is greatly hindered by the poor trans- mission of visible light. Q-dots act as the inor- ganic fluorophore for intra-operative detection of tumors using fluorescence spectroscopy as they are 20-times brighter and 100-times more stable than the traditional fluorescent report- ers [29]. The improved photostability of Q-dots allows the acquisition of many consecutive focal plane images that can be reconstructed into a high-resolution 3D image. The extraordinary stability makes them a probe to track cells or molecules over extended periods of time. The ability to image single-cell migration in real- time renders their importance in embryogen- esis, cancer metastasis, stem-cell therapeutics, lymphocyte immunology and in vitro imaging of prelabeled cells [30]. Fluorescent Q-dots can be tagged to antibodies that target cancerous cells or cells infected with tuberculosis or HIV [31], and could also be used to diagnose malaria by making them target the protein that forms a mesh in the blood cell’s inner membrane. The shape of this protein network changes when cells are infected with malaria, so scientists are able to spot malaria infection from the shape produced by the dots [32]. Q-dots have earned success in sentinel lymph node biopsy, a tech- nique that locates the first draining lymph node at the cancer site. The background tissue auto- fluorescence is an avid limitation of blue dye and radioisotopes used in biopsy, which is overcome by Q-dots emitting at the near-IR range. This allows surgeons to undertake biopsy with high accuracy and minimum invasiveness. Q-dot-fluorescence resonance energy transfer biosensors A fluorescence resonance energy transfer (FRET) is an energy transfer between two chro- mophores through dipole–dipole interactions. The process of energy transfer enjoys an inverse relationship to the sixth power of the distance between donor and acceptor molecules. FRET can wonderfully detect molecular interactions and conformations in biological systems. Q-dots can transfer their energy to quencher analytes through FRET, thus minimizing the fluores- cence from the Q-dot donor. Gold rods read- ily quench the fluorescence from the Q-dots. This exciting property of FRET between Q-dots and the surface of gold nanoparticles helps to explore many DNA properties [33]. The friend- ship between FRET technology and Q-dots can reduce background signal due to time-gating and increase the possibility of measuring long distances. FRET-based Q-dots biosensors have been developed to detect Aspergillus amstelodami. The Q-dots conjugated to IgG antibodies transfer their energy to quencher-labeled ana- lytes through FRET. The high-affinity target analytes replace the quencher analytes during detection to increase Q-dot fluorescence sig- nal. The sandwich immunoassay then detects Aspergillus, as low as 103 spores/ml, in 5 min. The idea can be further exploited to detect other biological threats [34]. Multiple colored Q-dots can tag various antibodies uniquely. Recently, researchers demonstrated a novel idea to multi- plex the utility of Q-dot biosensors, by applying simultaneous FRET to five different Q-dots on terbium complex with emission maxima at 529, 565, 604, 653 and 712 nm [35]. CdSe-ZnS core-shell Q-dots coated with dihydrolipoic acid and conjugated with human phosphoinositide-dependent protein kinase-1 have been designed to identify selective inhibi- tors of protein kinases. The response of this bio- sensor is tested in molecular dyad incorporating an ATP ligand and a chromophore. The organic dye allows nonspecific adsorption on the surface of nanoparticles promoting FRET from Q-dot to quencher dye. The assay demands study of new strategies to prevent energy adsorption on the nanoparticle donor surface [36]. Cochleates  Types, properties & synthesis of cochleates Types Cochleates are multilayered delivery vehicles made of alternating layers of divalent counter ions (Ca 2+ /Zn 2+ ) and bridging phospholipid bilayers, all rolled up in a spiral [37]. They are made up of three constituents: the lipid bilay- ers, the cations and the agent to be delivered; on varying one or more of these constituents, various permutation combinations are possible, as shown in box 1. Review | Loomba & Scarabelli The r. Del iv. (2013) 4(9) 1188 future science group Properties Cochleates are rod-like, rigid, internally hydro- phobic sheets made from small unilamellar lipo- somes condensed by bivalent cations. The positive charge on cations such as Zn 2+ , Ca 2+ , Mg 2+ and Ba 2+ interacts with negatively charged lipid to con- dense it and rolling further makes them resistant to their immediate environment. The high ten- sion at the bilayer edges of cochleates is the driv- ing force of cochleate’s interaction with the tissue membrane [38]. The cell membranes fuse with the lipid bilayer structure of cochleates, which unfolds to release the internal contents into cells. Another hypothesis put forward is the idea of phagocytosis for nanocochleates’ delivery. The phosphatidylser- ine receptors are common between the liposomal membranes of macrophages as well as those of cochleates. When in close proximity, the liposome membrane and the outer cochleate layer fuse to release the drugs into cell cytoplasm. The alternating lipid layers entrap the drug molecules without chemically bonding to it and potentially protect it from digestive enzymes in the stomach. Encochleation is a medium to extend the shelf-life of drugs because the cochle- ate cores are resistant to water and oxygen, two components that act as leading agents of drug decomposition and degradation. Synthesis Cochleates can be produced in submicron size using methods known as hydrogel-isolated cochleation, trapping, binary aqueous–aqueous emulsion, liposome before cochleates dialysis, direct calcium dialysis, or simply by increasing the ratio of multivalent cationic peptides over nega- tively charged liposomes. The hydrogel method immerses unilamellar liposomes loaded with drug in two sets of immiscible polymers. The polymer miscibility results in a two-phase aqueous system, which is crosslinked by a cation salt. The tiny cochleates so formed are washed and then sus- pended in a buffer. The trapping method involves dropwise addition of calcium salt and water phase to the formative layer of phosphatidylserine lipo- somes. The binary aqueous–aqueous emulsion method injects the primary dextran–liposome phase into a secondary non-miscible polyeth- ylene glycol polymer. The divalent cations are then diffused from one phase to another forming cochleates, less than 100 nm in size. The liposome before cochleates dialysis method suspends a detergent–lipid mixture in a two-phase polymer system. The mixture is dia- lyzed with a buffer to form protein–lipid vesi- cles. The cochleate precipitates from the vesicles by addition of calcium ions. Large needle-shaped cochleates are formed by the direct calcium dial- ysis method, in which lipid detergent mixture is dialyzed against CaCl 2 solution [39].  The cochleate technology for nanomedicine Cochleate means spiral shell. In 1975 Papah- adjopoulos and Wilschut discovered cigar-like nanocochleates nearly 500 nm in size. Since then, cochleates have been used to formulate a variety of biologically active molecules, mediate effective oral drug bioavailability and reduce toxicity. There is a budding interest of scientists to explore cochleate efficacy in gene delivery. Effective drug delivery by cochleates Cochleate technology is a new means of over- coming the poor oral absorption of drugs such as amphotericin B and to facilitate the bioral drug delivery of cochleate-administered oral doses of amphotericin B, ranging from 0 to 40 mg/kg of body weight/day fortnightly in a murine model of systemic aspergillosis. This leads to a reduction of more than two logs of colony counts in hepatic, pulmonary and renal organs [40]. Cochleates increase the efficacy of antibacterial drugs such as clofazimine used against tuberculosis. To protect mice from lethal acute graft-versus-host disease the immunosuppressive, water-insoluble com- pound 3-(2-ethylphenyl)-5-(3-methoxyphenyl)- 1H-1,2,4-triazole was subcutaneously adminis- tered through an oily vehicle. The oral admin- istration of 10 mg/kg of this compound after encochleation reduced lethality, and increased the survival rate to 100%, whereas the control with empty nanocochleates was inactive [41]. Cochleates serve as delivery vehicles for anti- inflammatory drugs such as naproxen, ibupro- fen and acetaminophen. Macrophages use the Box 1. The various constituents of a cochleate. Cations Lipids Drugs Zn 2+ , Ca 2+ , Mg 2+ , Ba 2+ Phosphotidylserine phosphatidic acid Phosphotidylinosotol Phosphotidyl Glycerol Phosphotidylcholine Phosphotidylethanolamine Diphosphotidylglycerol Dioleoyl phosphatidic acid Distearoyl phosphatidyl serine Dipalmitoylphosphatidylglycerol Protein Peptide Polynucleotide Antiviral agent Anaesthetic agent Anticancer agent Immunosuppressant Anti-inflammatory agent Tranquilizer Nutritional supplement Vitamins or Vasodilator agent [...]... Chen GF: Biosynthesis of nanoparticles by microorganisms and their applications J Nanomater 2011, 2011:270974 6 Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel Science 2006, 311(5761):622–627 7 Kreyling WG, Semmler-Behnke M, Moller W: Health implications of nanoparticles J Nanoparticle Res 2006, 8(5):543–562 8 Oberdorster G, Elder A, Rinderknecht A: Nanoparticles and the brain:... safety evaluation of nanomaterials Part VI Characterization of nanoscale particles for toxicological evaluation Toxicol Sci 2006, 90(2):296–303 51 Zook JM, Maccuspie RI, Locascio LE, Halter MD, Elliott JT: Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity Nanotoxicology 2011, 5(4):517–530 52 Kim S, Ryu DY: Silver nanoparticle-induced... Han et al Nanoscale Research Letters 2014, 9:459 http://www.nanoscalereslett.com/content/9/1/459 61 Kim TH, Kim M, Park HS, Shin US, Gong MS, Kim HW: Size-dependent cellular toxicity of silver nanoparticles J Biomed Mater Res Part A 2012, 100(4):1033–1043 62 Arora S, Jain J, Rajwade JM, Paknikar KM: Cellular responses induced by silver nanoparticles: In vitro studies Toxicol Lett 2008, 179(2):93–100... silver nanoparticles in Dalton's lymphoma ascites tumor model Int J Nanomedicine 2010, 5:753–762 39 Edetsberger M, Gaubitzer E, Valic E, Waigmann E, Kohler G: Detection of nanometer-sized particles in living cells using modern fluorescence fluctuation methods Biochem Biophysic Res Comm 2005, 332(1):109–116 40 Liu L, Ni F, Zhang J, Jiang X, Lu X, Guo Z, Xu R: Silver nanocrystals sensitize magnetic-nanoparticle-mediated... Bio and Nanotechnology, Coimbatore, Tamilnadu 641024, India 3Animal Biotechnology Division, National Institute of Animal Science, Suwon 441-350, Korea 1 Received: 1 July 2014 Accepted: 18 August 2014 Published: 2 September 2014 References 1 Chen X, Schluesener HJ: Nanosilver: a nanoproduct in medical application Toxicol Lett 2008, 176(1):1–12 2 Park EJ, Yi J, Kim Y, Choi K, Park K: Silver nanoparticles... KL, Jones RL, Schlager JJ: Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species J Phys Chem B 2008, 112(43):13608–13619 15 Asharani PV, Hande MP, Valiyaveettil S: Anti-proliferative activity of silver nanoparticles BMC Cell Biol 2009, 10:65 16 Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH: A case of generalized argyria after ingestion of colloidal... S, Wang J, Liu L, Li J, Yuan F, Xi T: Distribution, translocation and accumulation of silver nanoparticles in rats J Nanosci Nanotechnol 2009, 9(8):4924–4932 11 Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr, Hussain SM, Ali SF: Silver nanoparticle induced blood–brain barrier inflammation and increased permeability in primary... toxicity of nanoparticles in BRL 3A rat liver cells Toxicol In Vitro 2005, 19(7):975–983 18 Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ: The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion Toxicol Sci 2006, 92(2):456–463 19 Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH: Cellular toxicity of various inhalable metal nanoparticles... silver nanoparticles Langmuir 2011, 27(15):9165–9173 59 Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ Health Perspect 2005, 113(7):823–839 60 Miura N, Shinohara Y: Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells Biochem Biophys Res Commun 2009, 390(3):733–737 Han et al Nanoscale... epithelial cells Inhal Toxicol 2007, 19:59–65 Han et al Nanoscale Research Letters 2014, 9:459 http://www.nanoscalereslett.com/content/9/1/459 20 Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager JJ, Hussain SM, Hofmann MC: Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells Toxicol Sci 2010, 116(2):577–589 21 Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, . metallic nanoparticles have been embraced by nanotechnology for more than four decades now. Today, with Q-dots as new nanoball bearings, aluminosilicates as nanowire gauges, cochle- ates as nanocrystalline. Examples of metallic nanoparticles used as drugs and diagnostic agents. Metallic nanoparticles Element Use Aluminosilicate nanoparticles Al, Si Faster blood clotting in open wounds Nano biomagnets. promis- ing. Iron oxide nanoparticles (IONps) are avail- able in various dimensions and shapes such as nanorods, nanotubes, hollow fibers, rings and snowflakes. The iron oxide nanorods demonstrate